AMENDMENT TO AGREEMENTWohlberg Agreement • July 12th, 2007 • ImmunoCellular Therapeutics, Ltd. • Biological products, (no disgnostic substances)
THIS AMENDMENT to that certain agreement entered into as of October 30 2006 (the “Wohlberg Agreement”) by and between Optical Molecular Imaging, Inc., now known as ImmunoCellular Therapeutics, Ltd. (“ICT”) and David Wohlberg (“Wohlberg”) (together, the “Parties”) is entered into by the Parties with reference to the following facts:
